UBS Group set a €45.00 ($52.33) target price on Koninklijke Philips (AMS:PHIA) in a research report sent to investors on Thursday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.
PHIA has been the topic of several other research reports. HSBC set a €46.00 ($53.49) price target on Koninklijke Philips and gave the company a buy rating in a report on Friday, July 26th. Barclays set a €51.00 ($59.30) price target on Koninklijke Philips and gave the company a buy rating in a report on Friday, September 20th. Credit Suisse Group set a €42.00 ($48.84) price target on Koninklijke Philips and gave the company a neutral rating in a report on Tuesday, July 23rd. Deutsche Bank set a €49.00 ($56.98) price target on Koninklijke Philips and gave the company a buy rating in a report on Tuesday, September 24th. Finally, JPMorgan Chase & Co. set a €42.00 ($48.84) price target on Koninklijke Philips and gave the company a neutral rating in a report on Thursday. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock has a consensus rating of Buy and an average target price of €43.88 ($51.03).
Koninklijke Philips has a 52-week low of €28.92 ($33.63) and a 52-week high of €36.12 ($42.00).
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company’s segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease.
Further Reading: FAANG Stocks
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.